Real-world cardiometabolic protection outcomes
Official title: REal-world Data of CARdiometabolic ProtEcTion
Run by Sun Yat-sen University · NCT07038083 · Data updated 2026-11-12
This project will test whether common cardiometabolic risk factors predict death and major heart-related events in adults with hypertension, diabetes, obesity, dyslipidemia, or high uric acid.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40000 (estimated) |
| Sponsor | Sun Yat-sen University Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Status | Recruiting |
| Started | January 1, 2014 |
| Main results expected | January 1, 2044 |
| Study ends | January 1, 2044 |
| Registry record updated | June 26, 2025 |
| Trial ID | NCT07038083 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older treated at the First Affiliated Hospital of Sun Yat-sen University with a clinical diagnosis of hypertension, diabetes, overweight/obesity, dyslipidemia, or hyperuricemia are ideal candidates.
✕Probably not a fit
People without cardiometabolic conditions, those under 18, or patients treated exclusively outside the enrolling hospital with no accessible records are unlikely to benefit from this project.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center, historical prospective cohort uses clinical records from the First Affiliated Hospital of Sun Yat-sen University to follow adults diagnosed with cardiometabolic conditions. Eligible patients are those aged 18 or older with diagnoses such as hypertension, diabetes, overweight/obesity, dyslipidemia, or hyperuricemia based on standard clinical criteria. The primary outcomes are all-cause death and cardiovascular death, and the secondary outcome is major adverse cardiovascular events (MACE). The study will measure associations between established or suspected cardiometabolic risk factors and these outcomes in a real-world representative cohort.
Why it matters
Potential benefit: If successful, the findings could help clinicians identify which cardiometabolic risk factors most strongly predict death or major heart events and better target prevention and management.
How similar studies have gone: Large cohort studies have previously linked cardiometabolic risk factors to mortality and cardiovascular events, so this work seeks to confirm and refine those associations in a real-world Chinese hospital cohort.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients over 18 years old; * Patients with clinical diagnosis of metabolic cardiovascular disease, including hypertension, diabetes, obesity, dyslipidemia, hyperuricemia. 1. Hypertension and normal high blood pressure: Three standardized blood pressure measurements in the clinic on different days, and all the blood pressure values of the three measurements were systolic blood pressure ≥ 120 mmHg and/or diastolic blood pressure ≥ 80 mmHg; 2. Diabetes: ① Typical symptoms of diabetes, and any of the following: ② Random blood glucose ≥ 11.1 mmol/L; ③ Fasting blood glucose (FPG) ≥ 7.0 mmol/L; ④ OGTT 2-hour postprandial blood glucose ≥ 11.1 mmol/L; ⑤ HbA1c ≥ 6.5%; 3. Obesity and overweight: Body mass index (BMI) ≥ 24 kg/m²; 4. Dyslipidemia: At least one of the following lipid indicators is abnormal: ① Total cholesterol (TC) ≥ 6.2 mmol/L; ② Low-density lipoprotein cholesterol (LDL-C) ≥ 4.1 mmol/L; ③ High-density lipoprotein cholesterol (HDL-C) \< 1.0 mmol/L; ④ Triglyceride (TG) ≥ 2.3 mmol/L; ⑤ Lipoprotein(a) ≥ 30 mg/dL; 5. Hyperuricemia: The fasting blood uric acid levels on two different days were \> 420 μmol/L (7 mg/dL) in men and \> 360 μmol/L (6 mg/dL) in women. Exclusion Criteria: * Patients unable to provide informed consent.
Where it's running
-
The First Affiliated Hospital of Sun Yat-sen Univerity
Guangzhou, Guangdong, China Recruiting
Study contacts
- Study coordinator: Xiaodong Zhuang
- Email: zhuangxd3@mail.sysu.edu.cn
- Phone: +8613760755035
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Differentiating heart disease in autoimmune vs. type 2 diabetes
This study tests whether adult-onset autoimmune diabetes (AID/LADA) and type 2 diabetes (T2D) differ in how diabetic heart disease develops, using advanced heart imaging in people with AID, T2D, and healthy controls.
-
Cardio-Metabolic Clinic care for adults with type 2 diabetes and cardiovascular disease
This trial tests whether a specialized Cardio-Metabolic Clinic can improve heart function and overall health for adults with type 2 diabetes and cardiovascular disease compared with usual care.
-
A safe test of a new medicine for healthy adults
This study tests a new medicine called NNC0705-0002 in healthy adults to see if it is safe and how it behaves in the body.
-
Nutrition Counselling for people with diabetes and high blood pressure
Aimed at adults with both type 2 diabetes and hypertension, this study tests whether structured nutrition counselling helps people stick to better diets and improve health-related quality of life.
-
Maternal insulin and fat metabolism in pregnancies at risk for preeclampsia and gestational diabetes
This project will try to see if insulin resistance and how the body burns fats early in pregnancy predict later preeclampsia or gestational diabetes in people at higher risk.
-
SMILE: Tracking muscle loss, metabolic health, and aging over time
This project will follow adults to see if combining clinical data, imaging, and blood/tissue samples can detect and track muscle loss and metabolic changes linked to aging.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.